ArticleBrain and behavior2026
Passive Oscillatory Body Motion Attenuates Pain-Related Behaviors and Increases β-Endorphin Immunoreactivity in a Murine Fracture Model: A Preliminary Study.
Article in Brain and behavior, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
objectiveThis preliminary study aimed to investigate whether passive oscillatory body motion (PBM), a mechanical stimulus that reproduces vertical accelerations comparable to those generated during treadmill running, could activate the β-endorphin (β-END)-related hypothalamus-periaqueductal gray (PAG) pathway and alleviate fracture-induced pain.
methodsA murine fracture model was established in C57BL/6J mice by inducing a left tibial fracture followed by 3 weeks of immobilization. Mice were randomly divided into a PBM group and a control group, and PBM was initiated the day after fracture (±5 mm amplitude, 2 Hz, 30 min/day, 5 days/week, for 3 weeks). To measure pain thresholds, paw withdrawal thresholds were measured in an unblinded manner using the von Frey filament test. β-END immunoreactivity and opioid receptor mu 1 (Oprm1) mRNA in the PAG, as well as pro-opiomelanocortin (Pomc) mRNA expression in the hypothalamus, were analyzed by immunofluorescence and qPCR, respectively.
resultsPBM significantly increased the paw withdrawal threshold ratio (p < 0.001) and β-END immunoreactivity (p = 0.02) in the PAG. Moreover, as an exploratory observation, Pomc mRNA expression tended to increase in the PBM group (p = 0.07), whereas Oprm1 mRNA expression did not differ between the two groups (p = 0.69).
conclusionThis preliminary study provides initial evidence that PBM may attenuate fracture-induced pain-related behaviors and increase β-END immunoreactivity in the PAG, possibly via the hypothalamus-PAG pathway. PBM may represent a potential exercise-mimetic approach for pain relief, although further studies are needed to confirm its efficacy and underlying mechanisms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.